Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd (T14) Stock Price & News

All values in CNY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.02B	1.25B	1.52B	939.39M
Cost of goods sold	238.27M	394.31M	337.79M	292.96M
Cost of revenue	238.27M	394.31M	337.79M	292.96M
Research and development expenses	43.07M	85.19M	29.81M	50.15M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	514.66M	696.15M	625.03M	371.90M
Operating expense	563.62M	807.49M	677.84M	441.00M
Total operating expenses	801.90M	1.20B	1.02B	733.96M
Operating income	217.44M	45.67M	499.57M	205.42M
Other non operating income	-2.64M	1.48M	-450.84K	-152.55K
EBT including unusual items	253.19M	-32.76M	494.29M	258.05M
EBT excluding unusual items	265.54M	66.32M	529.85M	223.56M
Income tax expense	30.06M	2.71M	71.23M	37.55M
Effective tax rate	11.87%	-8.27%	14.41%	14.55%
Other operating expenses	5.74M	28.38M	20.68M	14.35M
Net income	224.56M	-21.16M	423.80M	220.94M
Net profit margin	22.03%	-1.70%	27.97%	23.52%
Earnings per share	-	-	-	-
Interest and investment income	52.79M	22.29M	33.73M	20.96M
Interest expense	-2.01M	-2.32M	-3.00M	-2.18M
Net interest expenses	50.78M	19.97M	30.73M	18.79M
Depreciation and amortization charges	-	-	-	-
EBITDA	247.23M	72.82M	526.71M	230.47M
Gain or loss from assets sale	74.81K	-2.83M	-	181.42K

Ask anything